Skip to main content
. Author manuscript; available in PMC: 2011 Apr 1.
Published in final edited form as: Psychoneuroendocrinology. 2009 Sep 16;35(3):451–459. doi: 10.1016/j.psyneuen.2009.08.007

Table 1.

Demographic and baseline data for the four experimental groups.

Placebo First CRH First


Standard Instruction Cognitive Intervention Standard Instruction Cognitive Intervention p
n 9 8 7 8
Sex (F/M) 5/4 3/5 2/5 4/4 .70
Age (years) 22.9 (4.0) 23.5 (4.0) 23.0 (4.6) 22.3 (7.0) .97
Weight (kg) 69.6 (15.1) 70.8 (12.2) 73.9 (4.5) 71.5 (11.6) .91
CRH Dose (mcg) 20.9 (4.5) 21.2 (3.7) 22.1 (1.4) 21.4 (3.5) .91
Beck Depression 1.0 (1.2) 1.9 (1.8) 0.30 (0.76) 1.3 (1.6) .23
Trait Anxiety 26.7 (5.0) 27.6 (5.3) 23.6 (2.1) 28.4 (5.9) .27
ASI 12.1 (5.8) 13.3 (9.7) 10.1 (5.1) 16.3 (8.5) .47
Stress 3.7 (1.4) 5.3 (1.5) 4.9 (1.3) 4.3 (1.8) .19

Numbers represent group means (±SD), except for “n”, and “sex”, where number of subjects is presented. F = females, M = males; CRH = corticotropin releasing hormone; ASI = Anxiety Sensitivity Index. Trait Anxiety was measured using the Spielberger State-Trait Anxiety Scale. Stress was measured using a 10 point Likert scale of subjectively experienced stress in the prior week.